Search research articles
Contact Us
Filters
Showing results (81-90 of 130) with videos related to
Page
of 13
Sort By:
European Journal of Neurology
|
November 28, 2022
Anti-neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia-a case report and review of the literature
Anina Schwarzwald, Anke Salmen, Alejandro Xavier León Betancourt, et al.
European Journal of Neurology
|
February 23, 2023
Anti-kelchlike protein 11 antibody-associated encephalitis: Two case reports and review of the literature
Alejandro León Betancourt, Anina Schwarzwald, Alban Millonig, et al.
CNS Neuroscience & Therapeutics
|
August 17, 2022
Multidimensional phenotyping of the post-COVID-19 syndrome: A Swiss survey study
Lara Diem, Anina Schwarzwald, Christoph Friedli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 6, 2025
Dissecting definitions of disability accrual in relapsing multiple sclerosis-Have we reached standardization yet?
Gabriel Bsteh, Stefanie Marti, Helly Hammer, et al.
Acta Neuropathologica Communications
|
June 18, 2026
Higher disease reactivation risk in women after fingolimod withdrawal
Marine Massy, Stefanie Marti, Adriane Kutllovci, et al.
Journal of Central Nervous System Disease
|
May 7, 2024
Different lymphocyte counts of multiple sclerosis patients treated with ofatumumab and ocrelizumab: A retrospective observational study
Christoph Friedli, Nik Krajnc, Helly N Hammer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 8, 2016
Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy
Robert Hoepner, Eva M Kolb, Stefanie Dahlhaus, et al.
Multiple Sclerosis and Related Disorders
|
December 11, 2024
Disability progression is a question of definition-A methodological reappraisal by example of primary progressive multiple sclerosis
Gabriel Bsteh, Stefanie Marti, Nik Krajnc, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 20, 2021
Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses
Brian T Wipke, Robert Hoepner, Katrin Strassburger-Krogias, et al.
Frontiers in Digital Health
|
June 15, 2026
Listening to MS: AI-assisted speech analysis for diagnosis and fatigue prediction (COMMITMENT)
Helly Hammer, Monica Gonzalez-Machorro, Pascal Hecker, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 130) with videos related to
Sort By:
Page
of 13
European Journal of Neurology
|
November 28, 2022
Anti-neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia-a case report and review of the literature
Anina Schwarzwald, Anke Salmen, Alejandro Xavier León Betancourt, et al.
European Journal of Neurology
|
February 23, 2023
Anti-kelchlike protein 11 antibody-associated encephalitis: Two case reports and review of the literature
Alejandro León Betancourt, Anina Schwarzwald, Alban Millonig, et al.
CNS Neuroscience & Therapeutics
|
August 17, 2022
Multidimensional phenotyping of the post-COVID-19 syndrome: A Swiss survey study
Lara Diem, Anina Schwarzwald, Christoph Friedli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 6, 2025
Dissecting definitions of disability accrual in relapsing multiple sclerosis-Have we reached standardization yet?
Gabriel Bsteh, Stefanie Marti, Helly Hammer, et al.
Acta Neuropathologica Communications
|
June 18, 2026
Higher disease reactivation risk in women after fingolimod withdrawal
Marine Massy, Stefanie Marti, Adriane Kutllovci, et al.
Journal of Central Nervous System Disease
|
May 7, 2024
Different lymphocyte counts of multiple sclerosis patients treated with ofatumumab and ocrelizumab: A retrospective observational study
Christoph Friedli, Nik Krajnc, Helly N Hammer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 8, 2016
Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy
Robert Hoepner, Eva M Kolb, Stefanie Dahlhaus, et al.
Multiple Sclerosis and Related Disorders
|
December 11, 2024
Disability progression is a question of definition-A methodological reappraisal by example of primary progressive multiple sclerosis
Gabriel Bsteh, Stefanie Marti, Nik Krajnc, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 20, 2021
Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses
Brian T Wipke, Robert Hoepner, Katrin Strassburger-Krogias, et al.
Frontiers in Digital Health
|
June 15, 2026
Listening to MS: AI-assisted speech analysis for diagnosis and fatigue prediction (COMMITMENT)
Helly Hammer, Monica Gonzalez-Machorro, Pascal Hecker, et al.
Page
of 13